A case report of locally invasive Aspergillus fumigatus infection in a patient on canakinumab

BACKGROUND: Canakinumab is a human monoclonal interleukin-1 antibody that has been studied in the Canakinumab Anti-Inflammatory Thrombosis Outcome Study (CANTOS) trial and shown to prevent recurrent cardiovascular events, while increasing the incidence of neutropenia and risk of severe infections. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandrakumaran, Anchalia, Malik, Manpreet, Stevens, Michael P, Abbate, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177092/
https://www.ncbi.nlm.nih.gov/pubmed/31020175
http://dx.doi.org/10.1093/ehjcr/yty098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177092/
https://www.ncbi.nlm.nih.gov/pubmed/31020175
http://dx.doi.org/10.1093/ehjcr/yty098

Ejemplares similares